XML 56 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
STOCK-BASED COMPENSATION  
Schedule of stock-based compensation expense

Years Ended

Six Months Ended

Fiscal Year Ended

December 31,

December 31,

December 31,

June 30,

    

2023

    

2022

    

2021

    

2021

Restricted stock

$

6,191

$

4,515

$

2,006

$

2,668

Performance stock

2,953

2,685

405

1,317

Stock appreciation rights

533

1,179

779

1,677

Stock options

19

32

28

68

Total stock-based compensation expense

$

9,696

$

8,411

$

3,218

$

5,730

Schedule of valuation assumptions

Stock Options

Years Ended

Six Months Ended

Fiscal Year Ended

December 31,

December 31,

December 31,

June 30,

2023

2022

2021

    

2021

    

Weighted-average expected volatility

    

%  

%  

%  

39.4

%  

Weighted-average expected life in years

 

 

 

 

4.4

 

Weighted-average dividend yield

 

%  

%  

%  

0.9

%  

Weighted-average risk-free interest rate

 

%  

%  

%  

0.2

%  

SSARs

 

Years Ended

Six Months Ended

Fiscal Year Ended

December 31,

December 31,

December 31,

June 30,

2023

2022

2021

2021

 

Weighted-average expected volatility

%  

%  

%  

39.2

%

Weighted-average expected life in years

 

 

 

4.2

Weighted-average dividend yield

%  

%  

%  

0.9

%

Weighted-average risk-free interest rate

%  

%  

%  

0.2

%

Summary of stock options activity

    

    

    

Weighted-

    

Weighted-

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic Value

Shares

Price

Life (Years)

(in thousands)

Outstanding at January 1, 2023

 

17,878

$

81.17

 

  

 

  

Exercised

 

(6,534)

$

71.39

 

  

 

  

Forfeited

 

$

 

  

 

  

Granted

 

$

 

  

 

  

Outstanding at December 31, 2023

 

11,344

$

86.80

 

3.4

$

431

Exercisable at December 31, 2023

 

11,344

$

86.80

 

3.4

$

431

Summary of SSARs activity

    

    

    

Weighted-

    

Weighted-

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic Value

Shares

Price

Life (Years)

(in thousands)

Outstanding at January 1, 2023

 

174,906

$

111.65

 

  

 

  

Exercised

 

(17,627)

$

99.34

 

  

 

  

Forfeited

 

$

 

  

 

  

Granted

 

$

 

  

 

  

Outstanding at December 31, 2023

 

157,279

$

113.03

 

5.2

$

2,526

Exercisable at December 31, 2023

 

157,279

$

113.03

 

5.2

$

2,526

Summary of non-vested awards

    

    

Weighted-

Average

Number of

Grant Date

Shares

Fair Value

Outstanding at January 1, 2023

 

166,441

$

122.05

Granted

 

82,740

$

139.50

Exercised

 

(5,847)

$

82.30

Non-attainment

 

(27,143)

$

79.84

Forfeited

 

$

Outstanding at December 31, 2023

 

216,191

$

135.11

Summary of the status of non-vested restricted stock

    

    

Weighted-

Average

Number of

Grant Date

Shares

Fair Value

Outstanding at January 1, 2023

 

120,542

$

116.76

Granted

 

56,710

$

120.67

Vested

 

(41,139)

$

115.24

Forfeited

 

$

Exercised

$

Outstanding at December 31, 2023

 

136,113

$

118.84